The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer
Abstract
BACKGROUND.: Because of scarce data from larger series and nonhomogeneous selection criteria, further information is needed on peritonectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) in managing patients with ovarian peritoneal carcinomatosis. METHODS.: In an open, prospective, single‐center nonrandomized phase 2 study conducted from November 2000 to April 2007, 47 patients with primary advanced or recurrent ovarian cancer and diffuse peritoneal carcinomatosis were enrolled; 22 underwent primary and 25 secondary cytoreduction plus immediate HIPEC followed by systemic chemotherapy. RESULTS.: The overall mean Sugarbaker peritoneal cancer index was 14.9 (range, 6–28). A mean of 6 surgical procedures were required per patient (range, 4–10). In 87.3% of the patients debulking achieved optimal cytoreduction (Sugarbaker completeness of cytoreduction [CC] score 0–1), whereas in 12.7% it left macroscopic residual disease (CC‐2 or CC‐3). Major complications developed in 21.3% of the patients and the in‐hospital mortality rate was 4.2%. The mean overall survival was 30.4 months, median survival was 24 months, and mean disease‐free survival was 27.4 months. Five‐year survival was 16.7%. Univariate (log‐rank test and analysis of variance) and multivariate analyses (Cox proportional‐hazard model) identified the CC score as the main factor capable of independently influencing survival. CONCLUSIONS.: Peritonectomy procedures combined with HIPEC offer promising long‐term survival in patients with diffuse peritoneal ovarian carcinomatosis. They achieve high adequate primary and secondary surgical cytoreduction rates with acceptable morbidity and mortality. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bozzetti, F., Braga, M., Gianotti, L., Gavazzi, C., & Mariani, L. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06578-3 · Cited by 494 · cited 1×
“Treatment-related morbidity and mortality were classified as grade 1: no complication; grade 2: minor complications; grade 3: major complications requiring reoperation, ICU admission, or interventional radiology; and grade 4: in-hospital mortality.(28)”
Background
Cited by
Chua, T. C., Yan, T. D., Saxena, A., & Morris, D. L. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a45d86 · Cited by 532
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Armstrong, D. K., Alvarez, R. D., Bakkum-Gamez, J. N., Barroilhet, L., Behbakht, K., Berchuck, A., Berek, J. S., Chen, L.-M., Cristea, M., DeRosa, M., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0039 · Cited by 309
Metadata
- Authors
- Di Giorgio, A., Naticchioni, E., Biacchi, D., Sibio, S., Accarpio, F., Rocco, M., Tarquini, S., Di Seri, M., Ciardi, A., Montruccoli, D., & Sammartino, P.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-07-08
- Volume
- 113
- Issue
- 2
- Pages
- 315-325
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2092761960
- Cited by
- 237
- References
- 1
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. https://app.cochat.ai/papers/10.1002/cncr.23553
- The paper
- Di Giorgio, A., Naticchioni, E., Biacchi, D., Sibio, S., Accarpio, F., Rocco, M., Tarquini, S., Di Seri, M., Ciardi, A., Montruccoli, D., & Sammartino, P. (2008). Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer. https://doi.org/10.1002/cncr.23553
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.